It is necessary to follow use of drugs so issued and prescribed for investigational therapies to all over the country and yet to be distributed by the DCGI

COVID-19 DRUGS FOR  INVESTIGATION:- The union ministry of health care system and control has asked the Drugs controller general of India to ensure equitable distribution of the Remdesivir  and Tocilizumab drugs which have been described and included as the investigational therapies in the national level treatment plans assessment realised with the protocol mentioned as for the covid-19 across the country. It has been asked to ascertain the situation and position of the coverage required to be verified by the DCGI in this behalf to make the vision clear that how many states are yet to be provided with the supply of above mentioned drugs by the respective companies who have been authorised to distribute the prescribed drugs required for the investigational therapies all over the country as per the schedule under instructions.